Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Clinical trial NCT00085189 · COMPLETED

Trial details

NCT number: NCT00085189
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Extraocular Extension Melanoma Iris Melanoma Metastatic Intraocular Melanoma Mucosal Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IIC Melanoma Stage IIIA Intraocular Melanoma Stage IIIA Melanoma Stage IIIB Intraocular Melanoma

Start date: 2004-05-01
Primary completion: 2007-09-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.